NOVARTIS Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>NI</div>
NOVARTIND -- India Stock  

INR 553.85  14.95  2.63%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding NOVARTIS INDIA LTD is 'Strong Sell'. Macroaxis provides NOVARTIS INDIA buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NOVARTIND positions. The advice algorithm takes into account all of NOVARTIS INDIA LTD available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from NOVARTIND buy-and-hold perspective. Additionally, see NOVARTIS INDIA Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool.

Search Advice


Time Horizon

Risk Tolerance

Execute Advice
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon NOVARTIS INDIA LTD has a mean deviation of 2.04, semi deviation of 0.0, standard deviation of 3.46, variance of 11.98, downside variance of 0.0 and semi variance of 0.0
Macroaxis provides buy or sell recommendations on NOVARTIS INDIA LTD to complement and cross-verify current analyst consensus">analyst consensus on NOVARTIS INDIA. Our advice engine determines the firm potential to grow exclusively from the perspective of investors current risk tolerance and investing horizon. To make sure NOVARTIS INDIA LTD is not overpriced, please verify all NOVARTIS INDIA LTD fundamentals, including its Cash per Share as well as the relationship between Cash Flow from Operations and Z Score .

NOVARTIS INDIA Trading Alerts and Improvement Suggestions

NOVARTIS INDIA LTD generates negative expected return over the last 30 days
NOVARTIS INDIA LTD has high historical volatility and very poor performance
N/A has accumulated about 6.49 B in cash with (283.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 262.92.

NOVARTIS INDIA current analysts recommendations

Target Median Price745.00
Target Mean Price745.00
Target High Price745.00
Number Of Analyst Opinions1
Target Low Price745.00
The consensus estimates and target price estimation is comprised of individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

NOVARTIS INDIA Returns Distribution Density

Mean Return-0.2Value At Risk-6.35
Potential Upside5.93Standard Deviation3.46
 Return Density 


Alpha over DOW
Beta against DOW=-0.09
Overall volatility
Information ratio =-0.02

NOVARTIS INDIA Volatility Alert

NOVARTIS INDIA LTD exhibits very low volatility with skewness of 0.18 and kurtosis of 4.0. However, we advise investors to further study NOVARTIS INDIA LTD technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare NOVARTIS INDIA to competition

NOVARTIS INDIA Fundamental Vs Peers

FundamentalsNOVARTIS INDIAPeer Average
Return On Equity3.86 (0.31) 
Return On Asset1.23 (0.14) 
Profit Margin5.02 (1.27) 
Operating Margin3.05 (5.51) 
Current Valuation8.73 B16.62 B
Shares Outstanding24.69 M571.82 M
Price to Earning59.72 28.72 
Price to Book1.89 9.51 
Price to Sales3.00 11.42 
Revenue4.55 B9.43 B
Gross Profit2.91 B27.38 B
EBITDA175.58 M3.9 B
Net Income228.3 M570.98 M
Cash and Equivalents6.49 B2.7 B
Cash per Share262.92 5.01 
Total Debt668 M5.32 B
Debt to Equity0.09 48.70 
Current Ratio3.09 2.16 
Book Value Per Share292.81 1.93 K
Cash Flow from Operations(283.4 M)971.22 M
Earnings Per Share9.26 3.12 
Number of Employees58118.84 K
Market Capitalization13.66 B19.03 B
Z Score12.08.72
Five Year Return1.47
Last Dividend Paid10.0

About NOVARTIS INDIA Buy or Sell Advice

When is the right time to buy or sell NOVARTIS INDIA LTD? Buying stocks such as NOVARTIS INDIA isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily bases. Although NOVARTIS INDIA investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply. Please read more on our stock advisor page.

Did You Try This Idea?

Run IT Thematic Idea Now

IT Theme
Information Technology (IT) companies and IT service providers across different domains. IT theme has 30 constituents.
View All  Next Launch IT
Additionally, see NOVARTIS INDIA Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page